Company: AEMD
Filing Date: 2025-04-08
Form Type: PRE 14A
Source: 0001683168-25-002332
Chunk: 13

Company: AETHLON MEDICAL INC
Filing Date: 2025-04-08
Form: PRE 14A
Chunk 13
---
,767 shares
of our common stock issued and outstanding. We believe that each individual or entity named has sole investment and voting power with
respect to shares of common stock indicated as beneficially owned by them, subject to community property laws where applicable, except
where otherwise noted. Unless otherwise indicated, the address for each person listed in the table below is c/o Aethlon Medical, Inc.,
11555 Sorrento Valley Road, Suite 203, San Diego, CA 92121.

| NAME OF BENEFICIAL OWNER                                                       |     | NUMBER OF SHARES BENEFICIALLY 
                      OWNED(1) |     | PERCENT OF SHARES BENEFICIALLY 
 OWNED(2)                       |
| Greater than 5% Stockholders                                                   |     |                               |     |                                |
| Ikarian Capital, LLC                                                           |     |                     1,229,285 |  -3 | 7.6%                           |
| Directors and Named Executive Officers                                         |     |                               |     |                                |
| James B. Frakes, Chief Executive Officer, Chief Financial Officer and Director |     |                        22,429 |  -4 | *                              |
| Edward G. Broenniman, Chairman and Director                                    |     |                        39,070 |  -5 | *                              |
| Chetan S. Shah, M.D., Director                                                 |     |                        31,375 |  -6 | *                              |
| Angela Rossetti, Director                                                      |     |                        49,660 |  -7 | *                              |
| Guy F. Cipriani, Senior Vice President, Chief Operating Officer                |     |                         1,791 |  -8 | *                              |
| Steven P. LaRosa, M.D., Chief Medical Officer                                  |     |                        21,238 |  -9 | *                              |
| Nicolas Gikakis, Director                                                      |     |                        31,462 | -10 | –                              |
| All Current Directors and Executive Officers as a Group (7 members)            |     |                       195,686 | -11 | 1.2%                           |

_____________________________

| * | Less than 1% |

| (1)  | Calculated pursuant to Rule 13d-3(d)(1) of the Exchange Act. Under Rule                                                               
 13d-3(d)(1), shares not outstanding that are subject to options, warrants, rights or conversion privileges exercisable by a person